With over 16 years of experience, Dr. Amini specializes in diagnosing and treating chronic kidney disease, hypertension, electrolyte disturbances, acute kidney injury, and pre- and post-kidney transplant care. He is dedicated to providing exceptional healthcare to patients in the Hampton Roads community and is board-certified in Nephrology. 

Dr. Amini’s commitment to enhancing patient care is evident in his role as the Director of Dialysis Units for both acute and chronic programs, overseeing the only nocturnal home hemodialysis unit in Hampton Roads. As a Medical Advisory Board member, he ensures that patients receive the highest standards of treatment and advocacy within the healthcare system. 

Dr. Amini, an associate professor, is dedicated to shaping the next generation of medical professionals. His passion for innovation is demonstrated by his role as an investigator for clinical trials and as a Medical Advisor for IQVIA, the largest Clinical Research Organization. He has contributed to 14 clinical trials worldwide, ranging from phase 1-4 and real-world evidence. Notably, he was part of the DAPA trial, which led to the FDA approval of Farxiga, and advised on Sparsantan trials for IgA nephropathy and FSGS. 

Dr. Amini’s expertise in healthcare economics is showcased in his book, “Universal Health Care Via Free Markets.” He has also chaired the Retirement Committee and served on the Board of Directors, demonstrating his dedication to TPMG’s growth and success. 

Dr. Amini holds an MBA from the prestigious William & Mary Mason School of Business in Williamsburg, Virginia. This academic achievement complements his medical expertise while enhancing his ability to deliver top-notch care and manage healthcare resources efficiently. 

With Dr. Reshad Amini as your nephrologist, you can rest assured that you are receiving expert care from a compassionate physician dedicated to advancing medical knowledge and enhancing patient well-being. 

 Professional Positions: 

• Medical Director, Fresenius Kidney Care, John Tyler Dialysis Unit, Williamsburg, VA, 2016 – Present 

• Medical Director, Fresenius Kidney Care, Denbigh Joint Venture Dialysis Unit, Newport News, VA, 2015 – Present 

• Medical Advisory Board Member, Fresenius Kidney Care, Eastern VA, 2017 – 2023 

Clinical Research: 

Sub Investigator 

•  Protocol D169AC00001 – A Study to Evaluate the Effect of XXX on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease: Randomized, Double-blind, Placebo-controlled, Event-driven, Parallel Group. Phase 3. 2018 to 2020 

• Protocol AKB-6548-CI-0014 – A Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of XXX for the Correction of Anemia in Subjects with Non-Dialysis-Dependent Chronic Kidney Disease. 2018 – Present